Evidence map›Paper›PMID 30313110›Full record

Observational studyMedicine2018

The association between IUGR and maternal inherited thrombophilias: A case-control study.

Stefan Dugalić, Milos Petronijevic, Aleksandar Stefanovic, Katarina Jeremic, Svetlana Vrzic Petronijevic, Ivan Soldatovic, Igor Pantic, Irena Djunic, Zoran Jokic, Filip Djokovic and 3 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Observational
  4. Article
  5. Predicting Thrombophilia in Preeclampsia: Is Universal Testing Necessary?Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Stefan DugalićClinical Center of Serbia, Clinic for Gynecology and Obstetrics.
Milos PetronijevicClinical Center of Serbia, Clinic for Gynecology and Obstetrics.
Aleksandar StefanovicClinical Center of Serbia, Clinic for Gynecology and Obstetrics.
Katarina JeremicClinical Center of Serbia, Clinic for Gynecology and Obstetrics.
Svetlana Vrzic PetronijevicClinical Center of Serbia, Clinic for Gynecology and Obstetrics.
Ivan SoldatovicSchool of Medicine, University of Belgrade.
Igor PanticSchool of Medicine, University of Belgrade.
Irena DjunicSchool of Medicine, University of Belgrade.
Zoran JokicFaculty of Health, Legal and Business Studies, Singidunum University, Valjevo.
Filip DjokovicFaculty of Health, Legal and Business Studies, Singidunum University, Valjevo.
Jelena DotlicClinical Center of Serbia, Clinic for Gynecology and Obstetrics.
Milica ZaricSchool of Medicine, University of Belgrade.
Jovana TodorovicSchool of Medicine, University of Belgrade.
University of Belgrade · RSSingidunum University · RSCentar za Promociju Nauke · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the risk factors for vascular obstetric complications, such as intrauterine growth restriction (IUGR), is inherited thrombophilias. Nevertheless, routine screening for thrombophilias is not endorsed in pregnant women due to their low prevalence and conflicting results of published studies regarding the usefulness of screening in these patients. The cause of IUGR remains unknown in almost 1 quarter of cases. There are no published studies evaluating the association of inherited thrombophilias and IUGR in patients with IUGR of unknown origin. Understanding and preventing IUGR is an important public health concern, as IUGR has been associated with fetal mortality and neonatal morbidity, as well as adverse long-standing consequences. This study aimed to evaluate the prevalence of inherited thrombophilias in IUGR of unknown cause and to test the association between the inherited thrombophilias and IUGR of unknown cause.This study included 33 cases of IUGR of unknown cause tested for inherited thrombophilias and 66 controls individually matched for age, ethnicity, and smoking status.Patients with plasminogen activator inhibitor 1 (PAI-1) and methylenetetrahydrofolate reductase (MTHFR) had significantly higher odds for IUGR of unknown cause (P < .001 and P = .002, respectively) with OR 13.546 (CI 95% 3.79-48.37) and 8.139 (CI 95% 2.20-30.10), respectively. A positive association between other inherited thrombophilias (homozygous 20210 prothrombin gene mutation and homozygous factor V Leiden) and IUGR of unknown cause was also found, P = .096, OR 6.106 (CI 95% 0.72-51.30), although it was not statistically significant (P = .096, OR = 6.106, CI 95% 0.72-51.30).Our results indicate that PAI-1 and MTHFR thrombophilias represent risk factors for IUGR of otherwise unidentified cause.

Indexed as

AdultBody Mass IndexCase-Control StudiesFemaleFetal Growth RetardationHumansMethylenetetrahydrofolate Reductase (NADPH2)Plasminogen Activator Inhibitor 1PregnancyRetrospective StudiesThrombophiliaMethylenetetrahydrofolate Reductase (NADPH2)Plasminogen Activator Inhibitor 1

Identifiers

PMID30313110
PMCPMC6203511
OpenAlexW2897590918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.